FTX Latest: Singh Lived in the ‘Nicest Room’ in the Penthouse
Nishad Singh, the former director of engineering at FTX, faces cross-examination at the Sam Bankman-Fried trial Tuesday.
FTX Latest: Singh Lived in the ‘Nicest Room’ in the Penthouse
Nishad Singh, the former director of engineering at FTX, faces cross-examination at the Sam Bankman-Fried trial Tuesday.
BNY Mellon Slides After Assets Miss Estimates, Deposits Decline
Shares of Bank of New York Mellon Corp. slumped the most in three months after the lender’s managed assets missed estimates and deposits fell.
HSBC Blocks Staff From Texting on Their Work Phones
HSBC Holdings Plc is blocking staff from texting on their work phones, in the latest fallout from regulatory probes into the industry’s use of unauthorized communication methods.
Thunberg Arrested as Climate Protest Disrupts Oil Event
Climate campaigner Greta Thunberg was arrested outside a major energy industry event in London, where crowds of protesters blocked several top oil executives from entering the venue.
JPMorgan Appoints Carsten Woehrn Co-Head of M&A in EMEA
JPMorgan Chase & Co. has appointed Carsten Woehrn as co-head of its mergers and acquisitions business in Europe, the Middle East and Africa, following a reshuffle of its leadership in the region.
Lucid’s Output of EVs Drops 29%, Putting Output Target at Risk
Lucid Group Inc.’s output of electric vehicles fell 29% on the quarter, raising questions about its ability to meet a full-year production target of more than 10,000 EVs.
Lucid’s Output of EVs Drops 29%, Putting Output Target at Risk
Lucid Group Inc.’s output of electric vehicles fell 29% on the quarter, raising questions about its ability to meet a full-year production target of more than 10,000 EVs.
Amazon Will Open Its Long-Awaited Retail Business in South Africa Next Year
Amazon.com Inc.’s long-awaited start of its online retail business in South Africa is planned for next year.
Thermo Fisher to Acquire Olink in $3.1 Billion Deal
Thermo Fisher Scientific Inc. will acquire Olink Holding AB in a deal that values the pharmaceutical products and services company at about $3.1 billion.